Navigation Links
Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine
Date:5/8/2008

ts. Such statements are subject to certain risk factors which may cause Vion's plans to differ or results to vary from those expected, including Vion's potential inability to obtain regulatory approval for its products, particularly Cloretazine(R) (VNP40101M), delayed or unfavorable results of drug trials, the possibility that favorable results of earlier preclinical studies or clinical trials are not predictive of safety and efficacy results in later clinical trials, the need for additional research and testing, the inability to manufacture product, the potential inability to secure external sources of funding to continue operations, the inability to access capital and funding on favorable terms, continued operating losses and the inability to continue operations as a result, and a variety of other risks set forth from time to time in Vion's filings with the Securities and Exchange Commission, including but not limited to the risks attendant to the forward-looking statements included under Item 1A, "Risk Factors" in Vion's Form 10-K for the year ended December 31, 2007. In particular, there can be no assurance as to the results of any of the Vion's clinical trials, that any of these trials will continue to full accrual, or that any of these trials will not be discontinued, modified, delayed or ceased altogether. Except in special circumstances in which a duty to update arises under law when prior disclosure becomes materially misleading in light of subsequent events, Vion does not intend to update any of these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

COMPANY CONTACT: Vion Pharmaceuticals, Inc.

Alan Kessman, Chief Executive Officer

Howard B. Johnson, President & CFO

(203) 498-4210


'/>"/>
SOURCE Vion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
2. Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer
3. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
4. Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates
5. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
6. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
7. Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals Nicotinic Alpha-7 Agonist, MEM 3454
8. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
9. ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
10. Cequent Pharmaceuticals Johannes Fruehauf, MD, Ph.D., to be Featured Speaker at RNAi World Congress in Boston - May 2, 2008
11. Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)...   Millstone Medical Outsourcing announced today that the ... Olive Branch, MS. Now totaling over 270,000 ... has added the capacity required to meet the high demand ... gives us the opportunity to grow in parallel with our ... "Two and a half years ago we were operating only ...
(Date:9/1/2015)... Sept. 1, 2015   Ivenix Inc. , ... management system, closed on a $42M round of ... Ventures. Cardinal Partners, CICA, Inc., Easterly Capital, Fidelity ... the round. This financing will support the company,s ... Leerink Partners LLC acted as the exclusive placement ...
(Date:9/1/2015)... 1. September 2015 In nur zwei ... Mitarbeitern hat die SHL Group schnell weltweit 3.000 ... rapides Wachstum auf dem Markt der ... und das Management von SHL wieder. ... ist weltweit führend in Design und Herstellung automatischer ...
Breaking Medicine Technology:Millstone Medical Outsourcing Announces Olive Branch Expansion 2Ivenix Inc. Secures $42 Million in Funding 2Ivenix Inc. Secures $42 Million in Funding 3SHL Group erreicht wichtigen Markstein von 3.000 Mitarbeitern 2
... ROSWELL, Ga., Sept. 1, 2011 Kimberly-Clark Health ... a double-digit price increase on synthetic exam gloves ... of raw materials, particularly butadiene and acrylonitrile.   ... for these raw materials along with inflationary pressures ...
... month, Floridians are recognizing "Plasma Protein Therapies Month," by ... throughout the "Sunshine State" and for the rare, genetic ... through plasma donation. Plasma protein therapies, which ... biotechnology product), are used every day to treat people ...
Cached Medicine Technology:Floridians Recognized for Role in Helping Rare Disease Patients Who Need Lifesaving Therapies 2Floridians Recognized for Role in Helping Rare Disease Patients Who Need Lifesaving Therapies 3
(Date:9/1/2015)... NY (PRWEB) , ... September 01, 2015 , ... ... non-profit organization devoted exclusively to funding innovative lymphoma research and serving the lymphoma ... – today announced its annual Light it Red for Lymphoma awareness initiative, the ...
(Date:9/1/2015)... ... , ... Celebrity hairstylist and Beauty Gives Back Art Team member Ted Gibson ... Thursday, Oct. 1, at the La Valencia Hotel. The presentation, on the eve of ... and professional hair, makeup and nail design. , The evening of beauty and ...
(Date:9/1/2015)... ... 01, 2015 , ... Philanthropic giving in the U.S. has been stuck at ... for Good 2015, released today by Camber Collective, goes to the root of this ... up to $22B in new philanthropic giving and shift $25B that’s already being donated, ...
(Date:9/1/2015)... ... ... Georgia State University and its partners have introduced a ... assaults on their campuses. , The free, evidence-based survey was developed by the ... student affairs professionals responding to calls by the Obama Administration to strengthen efforts ...
(Date:9/1/2015)... Rolling Meadows, Ill. (PRWEB) , ... September 01, ... ... medical procedures done by members of the American Society for Dermatologic Surgery, according ... case. , The 2015 ASDS Consumer Survey on Cosmetic Dermatologic Procedures – which ...
Breaking Medicine News(10 mins):Health News:Lymphoma Research Foundation Recognizes National Blood Cancer Awareness Month with Light it Red for Lymphoma Campaign 2Health News:Lymphoma Research Foundation Recognizes National Blood Cancer Awareness Month with Light it Red for Lymphoma Campaign 3Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 2Health News:Celebrity Hairstylist Ted Gibson Explores Fusion of Fashion and Beauty at “Beauty Behind the Fashion” at Fashion Week San Diego Proceeds to benefit THIRST Project 3Health News:Camber Collective Releases Money for Good 2015 - Revealing Root Causes to Why Charitable Giving Has Been Stuck at 2% GDP Since the 70s 2Health News:Camber Collective Releases Money for Good 2015 - Revealing Root Causes to Why Charitable Giving Has Been Stuck at 2% GDP Since the 70s 3Health News:Georgia State, Partners Introduce Climate Survey to Aid in Preventing Campus Sexual Assaults 2Health News:Survey: Consumers Prefer ASDS Members 2Health News:Survey: Consumers Prefer ASDS Members 3
... Texas, Nov. 19 Mott,s is getting sneaky this holiday season ... sneak Mott,s into classic holiday meals. As many Americans ... year, Mott,s and The Sneaky Chef have responded with a list ... for both kids and adults to enjoy. , "Between picky ...
... ... to be equally as effective as brand name drugs. , ... (PRWEB) November 19, 2009 -- A recent publication in the ... about generic drugs. A systematic review of 47 studies comparing the effectiveness of generic versus ...
... ... related to cancer and heart disease according to reliable research and that gum disease represents ... kidney cancer, pancreatic cancer and blood cell cancers, and that the public needs to ... of serious disease. , ...
... ... Alliance are launching personal health monitoring systems, including blood pressure, at the MEDICA ... wireless health devices to a new level of proven connectivity with the established ultra ... ...
... ... to perform feature based reverse engineering functions with new added functionality to capture ... ... Creative Dezign Concepts Inc today announced that DezignWorks, a feature based reverse ...
... ... Task Force Catch The New "Trillion-Dollar Madoff" In The Widespread $1 ... Shall Be The Equal Partners To The Federal Government In Fighting ... Roles In Conjunction With The Government Fraud Task Force To Save ...
Cached Medicine News:Health News:Mott's and The Sneaky Chef Give Holiday Favorites a Healthy Makeover 2Health News:Mott's and The Sneaky Chef Give Holiday Favorites a Healthy Makeover 3Health News:Generic Drugs Just as Effective as Brand Name Drugs Says DoctorSolve 2Health News:Diseased Gums Dramatically Raise Your Cancer and Health Risks 2Health News:Diseased Gums Dramatically Raise Your Cancer and Health Risks 3Health News:Diseased Gums Dramatically Raise Your Cancer and Health Risks 4Health News:Diseased Gums Dramatically Raise Your Cancer and Health Risks 5Health News:Leading Health Brands Demonstrate ANT+ Interoperability at MEDICA 2Health News:Leading Health Brands Demonstrate ANT+ Interoperability at MEDICA 3Health News:DezignWorks brings Intelligent Reverse Engineering capabilities to SolidWorks 2010 2Health News:DezignWorks brings Intelligent Reverse Engineering capabilities to SolidWorks 2010 3Health News:DezignWorks brings Intelligent Reverse Engineering capabilities to SolidWorks 2010 4Health News:DezignWorks brings Intelligent Reverse Engineering capabilities to SolidWorks 2010 5Health News:New Healthcare Overpayment Recoupment Embezzlement Recovery Service Announced In Wake Of Launch of New Federal Task Force To Combat Healthcare Fraud Crisis 2Health News:New Healthcare Overpayment Recoupment Embezzlement Recovery Service Announced In Wake Of Launch of New Federal Task Force To Combat Healthcare Fraud Crisis 3Health News:New Healthcare Overpayment Recoupment Embezzlement Recovery Service Announced In Wake Of Launch of New Federal Task Force To Combat Healthcare Fraud Crisis 4
...
No. 1. 30 mm conventional blades. Thin well-rounded tips....
Open blade speculum designed for both temporal and superior approach ocular surgery. Thumb screw adjusting mechanism. Manufactured in titanium....
Adjustable lid speculum angled 45 degrees with 17 mm curved solid blades and aspiration ports to remove excess fluid from around the eye during ocular procedures....
Medicine Products: